Verus Capital Partners LLC Has $331,000 Stock Holdings in Viemed Healthcare, Inc. $VMD

Verus Capital Partners LLC decreased its position in Viemed Healthcare, Inc. (NASDAQ:VMD) by 25.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 47,970 shares of the company’s stock after selling 15,950 shares during the period. Verus Capital Partners LLC owned about 0.12% of Viemed Healthcare worth $331,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of VMD. AQR Capital Management LLC bought a new stake in shares of Viemed Healthcare during the first quarter valued at approximately $90,000. Corton Capital Inc. boosted its stake in Viemed Healthcare by 45.4% during the first quarter. Corton Capital Inc. now owns 14,842 shares of the company’s stock worth $108,000 after buying an additional 4,634 shares in the last quarter. EntryPoint Capital LLC increased its holdings in Viemed Healthcare by 36.9% in the 1st quarter. EntryPoint Capital LLC now owns 15,706 shares of the company’s stock valued at $114,000 after buying an additional 4,232 shares during the period. Cardinal Point Capital Management ULC bought a new position in shares of Viemed Healthcare during the 2nd quarter worth about $128,000. Finally, R Squared Ltd boosted its position in shares of Viemed Healthcare by 276.5% during the 1st quarter. R Squared Ltd now owns 19,110 shares of the company’s stock valued at $139,000 after acquiring an additional 14,034 shares in the last quarter. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Price Performance

Shares of VMD stock opened at $6.55 on Thursday. Viemed Healthcare, Inc. has a 1 year low of $5.93 and a 1 year high of $9.68. The company has a current ratio of 1.13, a quick ratio of 1.01 and a debt-to-equity ratio of 0.14. The firm’s 50 day moving average is $6.73 and its 200-day moving average is $6.77. The firm has a market capitalization of $249.02 million, a price-to-earnings ratio of 19.85 and a beta of 1.29.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.09 EPS for the quarter, hitting the consensus estimate of $0.09. The company had revenue of $71.91 million during the quarter, compared to analysts’ expectations of $72.00 million. Viemed Healthcare had a net margin of 5.34% and a return on equity of 9.95%. Viemed Healthcare has set its FY 2025 guidance at EPS.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Viemed Healthcare in a report on Tuesday, October 14th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of “Hold”.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.